Cardio-oncology
Cardio-oncology
Cardio-oncology is a vital research area that addresses the intersection of cardiovascular health and cancer treatment. Its clinical importance lies in the understanding of cardiovascular risks associated with cancer treatment, which sometimes can cause complications like venous thromboembolism, stroke, myocardial infarction, and heart failure.
The goal of cardio-oncology is to enable patients to receive the most effective cancer treatments while minimizing cardiovascular toxicity and improving health of long-term cancer survivors.
Cardiovascular Platform – CLiPPeR in the U.S.
Published a series clinical course studies to understand patient characteristics which helped launch a novel PCSK9 medicine and informed their reimbursement strategy. These studies are essential to better understand patients’ disease progression.
Oncology Platform – OSCER in the U.S.
Produced several safety studies and publications to evaluate the risks and benefits of an approved blockbuster medicine as required by the health authorities in the U.S. The FDA and EMA often require safety studies.